Clinical Trial Update: A Study of NTX-1472 in Social Anxiety Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NTX-1472 for Social Anxiety Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• NTX-1472

Snippet

Sponsor: Newleos Therapeutics, Inc. | Conditions: Social Anxiety Disorder (SAD) | Phase 2 | Status: RECRUITING